Medicare Procedure and Patient Information
2022 Medicare Patient Data
Information about Medicare patients treated by Dr. Christopher Lake Littlejohn, MD.
| Non-Hispanic White | |
|---|---|
| Black | |
| Hispanic | |
| Asian | |
| Other | |
| Native American |
(No ratings)
Dr. Christopher Lake Littlejohn, MD is a medical oncologist in Dallas, TX specializing in medical oncology, adult oncology and adult hematology. He graduated from Texas A & M Health Science Center College of Medicine. Dr. Christopher Lake Littlejohn, MD is affiliated with Longview Regional Medical Center, CHRISTUS Health and Texas Oncology.
Longview Regional Medical Center
Click on any procedure below to see further details on volume and pricing among Medicare patients.
In 2023, Dr. Christopher Lake Littlejohn, MD had a list price for folic acid tests, and serum folate test that was lower than the list prices billed to Medicare by 95% of providers in related specialties within Texas. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
In 2023, Dr. Christopher Lake Littlejohn, MD had a list price for iron tests, lactate dehydrogenase (LDH) test, and metabolic panel that was lower than the list prices billed to Medicare by 90% of providers in related specialties within Texas. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
In 2013, Dr. Christopher Lake Littlejohn, MD had a list price for blood count tests, blood draw, blood draw for lab tests, liver function tests (LFTs), phlebotomy for lab tests, port flush, venipuncture (phlebotomy), and vitamin B12 test that was lower than the list prices billed to Medicare by 75% of providers in related specialties within Texas. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.
Information about Medicare patients treated by Dr. Christopher Lake Littlejohn, MD.
| Non-Hispanic White | 12 |
|---|---|
| Black | 0 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
The top procedures that Dr. Christopher Lake Littlejohn, MD treated as a medical oncologist in Dallas, TX during 2023 were lab tests, minimally invasive procedures, blood draw and chemotherapy.
Volume of procedures performed by Dr. Christopher Lake Littlejohn, MD for Medicare patients.
| biological response modifier (BRM) therapy | 105 |
|---|---|
| blood draw | 124 |
| chemotherapy | 105 |
| CT scan | 11 |
| doctor visit | 126 |
| lab tests | 389 |
| minimally invasive procedures | 165 |
| port flush | 22 |
| thoracic (chest) imaging | 11 |
Information about Medicare patients treated by Dr. Christopher Lake Littlejohn, MD.
| Male | 136 |
|---|---|
| Female | 167 |
| Non-Hispanic White | 259 |
|---|---|
| Black | 30 |
| Hispanic | 0 |
| Asian | 0 |
| Other | 0 |
| Native American | 0 |
| From 65 to 74 | 135 |
|---|---|
| From 75 to 84 | 113 |
| 85 and over | 42 |
| Less than 65 | 13 |
The most common conditions of Medicare patients that Dr. Christopher Lake Littlejohn, MD treated during 2023 were hypertension, high cholesterol, cancer and chronic kidney disease.
| Hypertension | 75 |
|---|---|
| High Cholesterol | 71 |
| Stroke | 12 |
| Ischemic Heart Disease | 36 |
| Depression | 21 |
| Chronic Kidney Disease | 38 |
| Asthma | 13 |
| Osteoperosis | 12 |
| Atrial Fibrilation | 27 |
| Heart Failure | 23 |
| Chronic Obstructive Pulmonary Disease | 28 |
| Diabetes | 33 |
| Dementia | 8 |
| Cancer | 48 |
Volume of procedures performed by Dr. Christopher Lake Littlejohn, MD for Medicare patients.
The highest averages for the top procedures that Dr. Christopher Lake Littlejohn, MD treated as a medical oncologist in Dallas, TX were lab tests, minimally invasive procedures, blood draw and chemotherapy.
| biological response modifier (BRM) therapy | 105 |
|---|---|
| blood draw | 124 |
| chemotherapy | 105 |
| CT scan | 11 |
| doctor visit | 126 |
| lab tests | 389 |
| minimally invasive procedures | 165 |
| thoracic (chest) imaging | 11 |
Information about Medicare patients treated by Dr. Christopher Lake Littlejohn, MD.
| Male | 68 |
|---|---|
| Female | 83 |
| Black / African American | 15 |
|---|---|
| Asian / Pacific Islander | 0 |
| Non-Hispanic White | 135 |
| Native American / Alaskan Native | 0 |
| Hispanic | 0 |
| Other | 0 |
| 75 to 84 | 56 |
|---|---|
| 85 and over | 21 |
| Less than 65 | 6 |
| 65 to 74 | 67 |
The highest averages of the most common conditions of Medicare patients that Dr. Christopher Lake Littlejohn, MD treated were high cholesterol, hypertension, cancer and chronic kidney disease.
| Hypertension | 37 |
|---|---|
| High Cholesterol | 35 |
| Stroke | 6 |
| Ischemic Heart Disease | 18 |
| Depression | 10 |
| Chronic Kidney Disease | 19 |
| Asthma | 6 |
| Osteoporosis | 6 |
| Heart Failure | 11 |
| Chronic Obstructive Pulmonary Disease | 14 |
| Diabetes | 16 |
| Atrial Fibrillation | 13 |
| Cancer | 24 |
| Dementia | 4 |
Dr. Christopher Lake Littlejohn, MD graduated from Texas A & M Health Science Center College of Medicine. He completed residency at Baylor University Medical Center. He is certified by the Certification: American Board of Internal Medicine and has a state license in Texas.
Medical School: Texas A & M Health Science Center College of Medicine
Residency: Baylor University Medical Center
Board Certification: Certification: American Board of Internal Medicine
Licensed In: Texas
Dr. Christopher Lake Littlejohn, MD is associated with these hospitals and organizations:
Dr. Christopher Lake Littlejohn, MD does not have any reviews yet, be the first to leave a review of Dr. Christopher Lake Littlejohn, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Christopher Lake Littlejohn, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| Incyte Corporation |
$619
JAKAFI $252 |
MONJUVI $209 |
PEMAZYRE $58 |
$100 |
||
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
$590
IMFINZI $215 |
LYNPARZA $125 |
TAGRISSO $100 |
IMJUDO $91 |
CALQUENCE $18 |
Other $41 |
| GlaxoSmithKline, LLC. |
$335
BLENREP $159 |
OJJAARA $93 |
JEMPERLI $20 |
SHINGRIX $18 |
ZEJULA $18 |
Other $27 |
| Janssen Biotech, Inc. |
$231
IMBRUVICA $98 |
TECVAYLI $80 |
CARVYKTI $53 |
|||
| Genentech USA, Inc. |
$161
TECENTRIQ $39 |
POLIVY $26 |
$96 |
|||
| Other |
$2,272
Kyprolis $145 |
Lenvima $125 |
BRUKINSA $117 |
OPDIVO $97 |
ADCETRIS $92 |
Other $1,696 |
| Food and Beverage | $4,043 |
|---|---|
| Education | $165 |
Dr. Christopher Littlejohn is a specialist in general practice, adult hematology, and adult oncology in Longview, TX, Dallas, TX, and Marshall, TX. Dr. Littlejohn is professionally affiliated with Longview Regional Medical Center, CHRISTUS Health, and Texas Oncology. He is a graduate of Texas A & M Health Science Center College of Medicine and a graduate of Baylor University Medical Center's residency program.